This educational webinar will aim to explain in simple language to a layperson audience the basic science behind BTK targeted therapies in use and study today to treat CLL.

7 December 2022 – CLLAN Webinar on “How are advances in Bruton’s tyrosine kinase targeted therapies continuing to change how chronic lymphocytic leukemia (CLL) is treated?”
18:00 – 19:00 CET / 17:00 – 18:00 GMT / 9:00 – 10:00 PST

Duration: 60 minute webinar
Audience: Patients, advocates, layperson stakeholders.

Acknowledgement

We would like to thank the following for their support: